IQ Biosciences

What makes iQ Biosciences different?

• High-quality human primary cells isolated from healthy blood donors sourced from a world-renowned blood centre.
• High-quality non-human primary cells isolated from peripheral blood or lymphoid tissues sourced responsibly from a vetted third-party facility.
• All orders come with an iQ Certificate of Analysis
• Normally ships out same business day.
• Custom projects to source rare biospecimens.
• In-house bioservices group experienced with immune-assays to offer guidance for use of primary cells.
• In-house functional testing of some primary cells by our own bioservices group for custom projects.

iQ additionally offers a range of bioservices for immunology research and development, including safety assessments and cytokine release assays. The company's services also include antibody-dependent cellular cytotoxicity (ADCC) assays, which measure the ability of antibodies to bind and kill target cells, and human Treg suppression assays, which assess the suppressive activity of regulatory T cells. These bioservices help researchers and drug developers better understand the immune system and develop effective immunotherapies.

IQ Biosciences supplies range of Peripheral Blood Mononuclear Cells (PBMCs) for scientific research purposes. PBMCs are a type of white blood cell that is found in the blood and plays an important role in the body's immune system.

IQ Biosciences isolates Peripheral Blood Mononuclear Cells (PBMCs) from human blood and offers them for sale to researchers studying various diseases and conditions such as cancer, autoimmune disorders, infectious diseases, and others. These PBMCs are available in a range of quantities, purity levels, and donor types, allowing researchers to select the appropriate product for their research needs.

By providing high-quality PBMCs in addition to a wide range of other reagents, IQ Biosciences enables researchers to conduct experiments that may lead to a better understanding of various diseases and ultimately, to the development of new treatments or therapies.